$PHCI
Panamera Holdings Corp

2022 Q1 Form 10-Q Financial Statement

#000164033422000515 Filed on March 17, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $6.240K $0.00
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $6.237K $4.684K
YoY Change 33.16% 1.06%
Operating Profit -$6.237K -$4.684K
YoY Change 33.16% 1.06%
Interest Expense $389.00 $1.457K
YoY Change -73.3% 21.72%
% of Operating Profit
Other Income/Expense, Net -$389.00 -$1.457K
YoY Change -73.3% 21.72%
Pretax Income -$6.626K -$6.141K
YoY Change 7.9% 5.3%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.626K -$6.141K
YoY Change 7.9% 5.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$169.10 $0.00
COMMON SHARES
Basic Shares Outstanding 39.21M shares 17.99M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00 $0.00
YoY Change
Cash & Equivalents $14.00 $148.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $10.00 $148.00
YoY Change -93.24% -96.44%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $10.00 $148.00
Total Long-Term Assets $0.00 $0.00
Total Assets $10.00 $148.00
YoY Change -93.24% -96.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.15K $10.00K
YoY Change 51.5% 0.0%
Accrued Expenses $10.00K
YoY Change 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $8.840K $120.0K
YoY Change -92.63% 20.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.98K $139.5K
YoY Change -82.81% 23.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $23.98K $139.5K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $23.98K $139.5K
YoY Change -82.81% 23.92%
SHAREHOLDERS EQUITY
Retained Earnings -$373.1K -$286.9K
YoY Change 30.05% 12.09%
Common Stock $3.921K $147.5K
YoY Change -97.34% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$23.97K -$139.4K
YoY Change
Total Liabilities & Shareholders Equity $14.00 $148.00
YoY Change -90.54% -96.44%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$6.626K -$6.141K
YoY Change 7.9% 5.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$3.350K $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.350K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -3.350K 0.000
Cash From Investing Activities
Cash From Financing Activities 3.350K 0.000
Net Change In Cash 0.0000000000009095 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$3.350K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Shell Company
EntityShellCompany
true
CY2022Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
15147 USD
CY2021Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
13514 USD
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
8836 USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1608 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
23983 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15122 USD
CY2022Q1 us-gaap Liabilities
Liabilities
23983 USD
CY2021Q3 us-gaap Liabilities
Liabilities
15122 USD
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39210000 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
3921 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
3921 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
345239 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
344963 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-373129 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-363996 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-23969 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-15112 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10 USD
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
5305 USD
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
4332 USD
us-gaap Professional Fees
ProfessionalFees
5333 USD
us-gaap Professional Fees
ProfessionalFees
14835 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
932 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
352 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3344 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
585 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
6237 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
4684 USD
us-gaap Operating Expenses
OperatingExpenses
15420 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6237 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4684 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8677 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-15420 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
389 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
1457 USD
us-gaap Interest Expense
InterestExpense
456 USD
us-gaap Interest Expense
InterestExpense
2853 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-389 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1457 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-456 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2853 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6626 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6141 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-9133 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-18273 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6626 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6141 USD
us-gaap Net Income Loss
NetIncomeLoss
-18273 USD
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39210000 shares
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39210000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-15112 USD
CY2021Q4 pnht Impactd Interest On Related Party Loan
ImpactdInterestOnRelatedPartyLoan
67 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2507 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-17552 USD
CY2022Q1 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
209 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6626 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-23969 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-121095 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6141 USD
us-gaap Net Income Loss
NetIncomeLoss
-9133 USD
us-gaap Net Income Loss
NetIncomeLoss
-18273 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
276 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1633 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2886 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2853 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7224 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12534 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7228 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
10450 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7228 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10450 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2084 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2232 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at January 31, 2022. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on the Company’s ability to identify and/or consummate an acceptable merger or acquisition transaction.</p>
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7228 USD
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
8836 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
276 USD
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39210000 shares

Files In Submission

Name View Source Status
0001640334-22-000515-index-headers.html Edgar Link pending
0001640334-22-000515-index.html Edgar Link pending
0001640334-22-000515.txt Edgar Link pending
0001640334-22-000515-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pnht-20220131.xsd Edgar Link pending
pnht-20220131_cal.xml Edgar Link unprocessable
pnht-20220131_def.xml Edgar Link unprocessable
pnht-20220131_lab.xml Edgar Link unprocessable
pnht-20220131_pre.xml Edgar Link unprocessable
pnht_10q.htm Edgar Link pending
pnht_10q_htm.xml Edgar Link completed
pnht_ex311.htm Edgar Link pending
pnht_ex312.htm Edgar Link pending
pnht_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending